Anticompetitive Conduct in Biologics – An Enforcement Priority with FTC and FDA

February 5, 2020

Anticompetitive Conduct in Biologics – An Enforcement Priority with FTC and FDA

February 4, 2020

Recent Merger Reviews Demonstrate Increased FTC and DOJ Focus on Acquisitions of Nascent Competitors

January 13, 2020

FTC Ratchets up Scrutiny on Pharmaceutical Deals

October 15, 2019

Second Circuit Rejects Total Wine Challenge of Connecticut Pricing Laws

March 5, 2019

Second Circuit Rejects Total Wine Challenge of Connecticut Pricing Laws

March 4, 2019

THE LATEST: AAG Delrahim Withdraws Statement on Remedies for Standards-Essential Patents Subject to Voluntary FRAND Commitments, Elaborates Views on SSOs

December 19, 2018

THE LATEST: FTC Submits Comment on FDA Guidance Aimed at Deterring Abuse of Citizen Petition Process

December 11, 2018

FTC to Look Closely at Competition between Biologics and Biosimilars and Patent Protection Strategies of Branded Manufacturers

July 24, 2018

THE LATEST: FTC to Look Closely at Competition between Biologics and Biosimilars and Patent Protection Strategies of Branded Manufacturers

July 24, 2018